STOCK TITAN

[144] UiPath, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

UiPath, Inc. (PATH) filed a Form 144 reporting a proposed sale of 1,000,000 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $12,900,000. The filing states these are founders' shares acquired on 04/21/2021 and indicates the sale is expected on or about 10/06/2025 on the NYSE. The filer represents no undisclosed material information and notes prior Rule 10b5-1 program sales totaling multiple transactions in the past three months, including repeated daily lots of 122,733 shares and several blocks of 45,000 shares, producing gross proceeds listed per trade. The notice identifies total shares outstanding as 453,568,899, which frames the proposed sale as a small fraction of the outstanding base.

UiPath, Inc. (PATH) ha depositato un Form 144 riferendo una vendita proposta di 1,000,000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC con un valore di mercato aggregato di $12,900,000. Il deposito indica che si tratta di azioni dei fondatori acquisite il 04/21/2021 e segnala che la vendita è prevista intorno al 10/06/2025 sul NYSE. Il dichiarante non rappresenta informazioni materiali non divulgate e nota vendite precedenti del programma Rule 10b5-1 che consistono in molteplici transazioni negli ultimi tre mesi, inclusi lotti giornalieri ripetuti di 122,733 azioni e diversi blocchi di 45,000 azioni, producendo proventi lordi per operazione. L'avviso identifica azioni in circolazione totali pari a 453,568,899, che inquadra la vendita proposta come una piccola frazione dell'offerta in circolazione.

UiPath, Inc. (PATH) presentó un Formulario 144 informando una venta propuesta de 1,000,000 acciones comunes a través de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $12,900,000. La presentación indica que estas son acciones de los fundadores adquiridas el 04/21/2021 e indica que la venta se espera para el o alrededor del 10/06/2025 en la NYSE. El declarante no representa información material no divulgada y señala ventas anteriores del programa Rule 10b5-1 que abarcan múltiples transacciones en los últimos tres meses, incluyendo lotes diarios repetidos de 122,733 acciones y varios bloques de 45,000 acciones, generando ingresos brutos por operación. El aviso identifica un total de acciones en circulación de 453,568,899, lo que enmarca la venta propuesta como una pequeña fracción de la base en circulación.

UiPath, Inc. (PATH)은 Morgan Stanley Smith Barney LLC를 통해 1,000,000 주의 보통주를 판매하려는 제안된 판매를 보고하는 Form 144를 제출했습니다. 총 시장 가치로 $12,900,000입니다. 제출서는 이것들이 창업자 주식으로 2021-04-21에 취득되었고, 판매가 2025-10-06 경 NYSE에서 예상된다고 명시합니다. 제출인은 비공개된 중요한 정보가 없다고 말하며 지난 3개월간의 규칙 10b5-1 프로그램 판매로 다수의 거래가 있었다고 지적합니다. 매일 반복된 122,733 주의 묶음 매입과 45,000 주의 여러 블록을 포함하여 총 거래당 매출이 기재되어 있습니다. 공지에는 발행 주식 총수가 453,568,899주로 식별되며, 이는 제안된 매각이 매도잔액의 작은 부분임을 보여줍니다.

UiPath, Inc. (PATH) a déposé un Form 144 déclarant une vente proposée de 1,000,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC pour une valeur de marché globale de $12,900,000. Le dépôt indique que ce sont des actions des fondateurs acquises le 04/21/2021 et indique que la vente est prévue vers le 10/06/2025 sur le NYSE. Le déposant déclare qu'il ne détient pas d'informations matérielles non divulguées et note des ventes antérieures du programme Rule 10b5-1 totalisant plusieurs transactions au cours des trois derniers mois, y compris des lots quotidiens répétés de 122,733 actions et plusieurs blocs de 45,000 actions, générant des produits bruts par transaction. L'avis identifie le total des actions en circulation à 453,568,899, ce qui cadre la vente proposée comme une petite fraction de la base en circulation.

UiPath, Inc. (PATH) hat ein Formular 144 eingereicht und einen vorgeschlagenen Verkauf von 1,000,000 Stammaktien über Morgan Stanley Smith Barney LLC gemeldet, mit einem aggregierten Marktwert von $12,900,000. Die Einreichung gibt an, dass es sich um Gründeraktien handelt, die am 04/21/2021 erworben wurden, und weist darauf hin, dass der Verkauf voraussichtlich am oder um den 10/06/2025 an der NYSE erfolgen wird. Der Einreicher erklärt, dass keine unbekannten wesentlichen Informationen vorliegen und verweist auf frühere Verkäufe im Rahmen des Regel-10b5-1-Programms, die in den letzten drei Monaten mehrere Transaktionen umfassen, einschließlich wiederholter täglicher Losgrößen von 122,733 Aktien und mehrerer Blöcke von 45,000 Aktien, wodurch Bruttogewinne pro Handel angegeben werden. Die Mitteilung identifiziert insgesamt ausstehende Aktien von 453,568,899, was den geplanten Verkauf als kleinen Bruchteil der bestehenden Basis einordnet.

UiPath, Inc. (PATH) قدمت نموذج 144 للإبلاغ عن بيع مقترح لـ 1,000,000 سهم عادي من خلال Morgan Stanley Smith Barney LLC بقيمة سوقية إجمالية قدرها $12,900,000. يذكر الإيداع أن هذه هي أسهم المؤسسين التي اشتُريت في 04/21/2021 ويشير إلى أن البيع من المتوقع أن يتم في أو حوالى 10/06/2025 في NYSE. المقدم يقر بأنه لا توجد معلومات مادية غير مُعلنة ويشير إلى مبيعات سابقة ضمن برنامج Rule 10b5-1 تشمل عدة صفقات خلال الثلاثة أشهر الماضية، بما في ذلك حزم يومية متكررة من 122,733 سهماً وكتل من 45,000 سهماً، مع تسجيل العوائد الإجمالية لكل صفقة. يحدد الإشعار إجمالي الأسهم المصدرة (المتاحة) بـ 453,568,899، مما يجعل البيع المقترح جزءاً صغيراً من القاعدة القائمة.

UiPath, Inc. (PATH) 提交了 Form 144,报告拟通过 Morgan Stanley Smith Barney LLC 出售 1,000,000 股普通股,市场总值为 $12,900,000。 filing 表示这是在 04/21/2021 取得的创始人股(founders' shares),并指出拟于大约 10/06/2025NYSE 进行出售。 提交人表示没有未披露的重大信息,并指出在过去三个月内按 Rule 10b5-1 计划进行的多笔交易的前次销售,包括每日重复的 122,733 股,以及若干笔 45,000 股的块,按交易列出毛收入。 通知标识总发行在外股票为 453,568,899 股,这使拟议的出售成为在外基础的一小部分。

Positive
  • Sale size is modest at 1,000,000 shares (~0.22% of outstanding)
  • Seller used Rule 10b5-1 program previously, showing pre-arranged trading activity
Negative
  • Founder share sale could marginally increase free float and selling pressure around 10/06/2025

Insights

TL;DR: A founder sale under Rule 144 is planned and prior 10b5-1 sales were executed recently.

The filing records a proposed sale of $12,900,000 worth of common stock (1,000,000 shares) sourced from founders' shares acquired on 04/21/2021. The transaction is routed through Morgan Stanley Smith Barney LLC and scheduled for 10/06/2025, with trades expected on the NYSE.

Compliance-wise, the notice includes the required representation that the seller is unaware of undisclosed material information and documents a history of Rule 10b5-1 sales in the prior three months. Watch for filings confirming execution details and any updates to the 10b5-1 plan timing within the next few trading days.

TL;DR: Sale size is modest relative to the share base but will increase circulating float slightly.

The proposed 1,000,000-share sale represents roughly 0.22% of the reported 453,568,899 shares outstanding, so the direct dilution or float increase is small in percentage terms. Prior 10b5-1 sales listed show repeated daily lots of 122,733 shares and blocks of 45,000 shares that have already generated multi-million dollar proceeds.

Investors may monitor short-term volume and any further insider dispositions; near-term impact is likely limited given the small percentage of outstanding shares, but execution timing could influence daily trading volumes around 10/06/2025.

UiPath, Inc. (PATH) ha depositato un Form 144 riferendo una vendita proposta di 1,000,000 azioni ordinarie tramite Morgan Stanley Smith Barney LLC con un valore di mercato aggregato di $12,900,000. Il deposito indica che si tratta di azioni dei fondatori acquisite il 04/21/2021 e segnala che la vendita è prevista intorno al 10/06/2025 sul NYSE. Il dichiarante non rappresenta informazioni materiali non divulgate e nota vendite precedenti del programma Rule 10b5-1 che consistono in molteplici transazioni negli ultimi tre mesi, inclusi lotti giornalieri ripetuti di 122,733 azioni e diversi blocchi di 45,000 azioni, producendo proventi lordi per operazione. L'avviso identifica azioni in circolazione totali pari a 453,568,899, che inquadra la vendita proposta come una piccola frazione dell'offerta in circolazione.

UiPath, Inc. (PATH) presentó un Formulario 144 informando una venta propuesta de 1,000,000 acciones comunes a través de Morgan Stanley Smith Barney LLC con un valor de mercado agregado de $12,900,000. La presentación indica que estas son acciones de los fundadores adquiridas el 04/21/2021 e indica que la venta se espera para el o alrededor del 10/06/2025 en la NYSE. El declarante no representa información material no divulgada y señala ventas anteriores del programa Rule 10b5-1 que abarcan múltiples transacciones en los últimos tres meses, incluyendo lotes diarios repetidos de 122,733 acciones y varios bloques de 45,000 acciones, generando ingresos brutos por operación. El aviso identifica un total de acciones en circulación de 453,568,899, lo que enmarca la venta propuesta como una pequeña fracción de la base en circulación.

UiPath, Inc. (PATH)은 Morgan Stanley Smith Barney LLC를 통해 1,000,000 주의 보통주를 판매하려는 제안된 판매를 보고하는 Form 144를 제출했습니다. 총 시장 가치로 $12,900,000입니다. 제출서는 이것들이 창업자 주식으로 2021-04-21에 취득되었고, 판매가 2025-10-06 경 NYSE에서 예상된다고 명시합니다. 제출인은 비공개된 중요한 정보가 없다고 말하며 지난 3개월간의 규칙 10b5-1 프로그램 판매로 다수의 거래가 있었다고 지적합니다. 매일 반복된 122,733 주의 묶음 매입과 45,000 주의 여러 블록을 포함하여 총 거래당 매출이 기재되어 있습니다. 공지에는 발행 주식 총수가 453,568,899주로 식별되며, 이는 제안된 매각이 매도잔액의 작은 부분임을 보여줍니다.

UiPath, Inc. (PATH) a déposé un Form 144 déclarant une vente proposée de 1,000,000 actions ordinaires par l'intermédiaire de Morgan Stanley Smith Barney LLC pour une valeur de marché globale de $12,900,000. Le dépôt indique que ce sont des actions des fondateurs acquises le 04/21/2021 et indique que la vente est prévue vers le 10/06/2025 sur le NYSE. Le déposant déclare qu'il ne détient pas d'informations matérielles non divulguées et note des ventes antérieures du programme Rule 10b5-1 totalisant plusieurs transactions au cours des trois derniers mois, y compris des lots quotidiens répétés de 122,733 actions et plusieurs blocs de 45,000 actions, générant des produits bruts par transaction. L'avis identifie le total des actions en circulation à 453,568,899, ce qui cadre la vente proposée comme une petite fraction de la base en circulation.

UiPath, Inc. (PATH) hat ein Formular 144 eingereicht und einen vorgeschlagenen Verkauf von 1,000,000 Stammaktien über Morgan Stanley Smith Barney LLC gemeldet, mit einem aggregierten Marktwert von $12,900,000. Die Einreichung gibt an, dass es sich um Gründeraktien handelt, die am 04/21/2021 erworben wurden, und weist darauf hin, dass der Verkauf voraussichtlich am oder um den 10/06/2025 an der NYSE erfolgen wird. Der Einreicher erklärt, dass keine unbekannten wesentlichen Informationen vorliegen und verweist auf frühere Verkäufe im Rahmen des Regel-10b5-1-Programms, die in den letzten drei Monaten mehrere Transaktionen umfassen, einschließlich wiederholter täglicher Losgrößen von 122,733 Aktien und mehrerer Blöcke von 45,000 Aktien, wodurch Bruttogewinne pro Handel angegeben werden. Die Mitteilung identifiziert insgesamt ausstehende Aktien von 453,568,899, was den geplanten Verkauf als kleinen Bruchteil der bestehenden Basis einordnet.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does UiPath's (PATH) Form 144 report?

It reports a proposed sale of 1,000,000 common shares valued at $12,900,000, expected on 10/06/2025, through Morgan Stanley Smith Barney LLC on the NYSE.

Are the shares being sold insider or founder shares for PATH?

Yes; the filing lists the securities as founders' shares acquired on 04/21/2021.

How large is the proposed sale versus UiPath's outstanding shares?

The proposed 1,000,000 shares equal about 0.22% of the reported 453,568,899 shares outstanding.

Has there been recent insider selling by this account?

Yes; the filing lists multiple recent Rule 10b5-1 sales in the past three months, including repeated daily lots of 122,733 shares.

Who is the broker handling the sale for PATH?

The broker named is Morgan Stanley Smith Barney LLC, address provided in the filing.
Uipath Inc

NYSE:PATH

PATH Rankings

PATH Latest News

PATH Latest SEC Filings

PATH Stock Data

6.85B
409.22M
9.44%
82.2%
10.47%
Software - Infrastructure
Services-prepackaged Software
Link
United States
NEW YORK